References
1. VG H. The bronchodilator action of magnesium and its antagonistic
action (dilator action) against pilocarpine, histamine and barium
chloride. . J Pharmacol Exp Ther. 1938;64.
2. Stenberg RG, Winniford MD, Hillis LD, Dowling GP, Buja LM.
Simultaneous acute thrombosis of two major coronary arteries following
intravenous cocaine use. Arch Pathol Lab Med. 1989;113(5):521-4.
3. Jones LA, Goodacre S. Magnesium sulphate in the treatment of acute
asthma: evaluation of current practice in adult emergency departments.
Emerg Med J. 2009;26(11):783-5.
4. Shan Z, Rong Y, Yang W, Wang D, Yao P, Xie J, et al. Intravenous and
nebulized magnesium sulfate for treating acute asthma in adults and
children: a systematic review and meta-analysis. Respir Med.
2013;107(3):321-30.
5. D’Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth
muscle by decreasing intracellular Ca2+ without changing intracellular
Mg2+. J Clin Invest. 1992;89(6):1988-94.
6. Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, et
al. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a
randomised, placebo-controlled trial. Lancet Respir Med.
2013;1(4):301-8.
7. Irazuzta JE, Chiriboga N. Magnesium sulfate infusion for acute asthma
in the emergency department. J Pediatr (Rio J). 2017;93 Suppl 1:19-25.
8. Su Z, Li R, Gai Z. Intravenous and Nebulized Magnesium Sulfate for
Treating Acute Asthma in Children: A Systematic Review and
Meta-Analysis. Pediatr Emerg Care. 2018;34(6):390-5.
9. Vergara C, Caraballo L. Asthma mortality in Columbia. Ann Allergy
Asthma Immunol. 1998;80(1):55-60.
10. Forno E, Gogna M, Cepeda A, Yanez A, Sole D, Cooper P, et al. Asthma
in Latin America. Thorax. 2015;70(9):898-905.
11. Rodriguez Martinez CE, Guzman MC, Castillo JM, Sossa MP, Ojeda P.
Evaluation of clinical criteria for the acute respiratory distress
syndrome in pediatric patients. Pediatr Crit Care Med. 2006;7(4):335-9.
12. Dennis RJ, Caraballo L, Garcia E, Rojas MX, Rondon MA, Perez A, et
al. Prevalence of asthma and other allergic conditions in Colombia
2009-2010: a cross-sectional study. BMC Pulm Med. 2012;12:17.
13. Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA.
Metered-dose inhalers vs nebulization for the delivery of albuterol in
pediatric asthma exacerbations: A cost-effectiveness analysis in a
middle-income country. Pediatr Pulmonol. 2020;55(4):866-73.
14. Neffen H, Moraes F, Viana K, Di Boscio V, Levy G, Vieira C, et al.
Asthma severity in four countries of Latin America. BMC Pulm Med.
2019;19(1):123.
15. Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA.
Predictors of hospitalization for asthma in children: results of a
1-year prospective study. Pediatr Pulmonol. 2014;49(11):1058-64.
16. Rampersad N, Wilkins B, Egan JR. Outcomes of paediatric critical
care asthma patients. J Paediatr Child Health. 2018;54(6):633-7.
17. Scarfone RJ, Loiselle JM, Joffe MD, Mull CC, Stiller S, Thompson K,
et al. A randomized trial of magnesium in the emergency department
treatment of children with asthma. Ann Emerg Med. 2000;36(6):572-8.
18. Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for
moderate to severe pediatric asthma: results of a randomized,
placebo-controlled trial. J Pediatr. 1996;129(6):809-14.
19. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous
magnesium therapy for children with moderate to severe acute asthma.
Arch Pediatr Adolesc Med. 2000;154(10):979-83.
20. Estadisticas DAN. Índice de Precios al Consumidor - IPC 2020
[Available from:https://www.dane.gov.co/index.php/estadisticas-por-tema/precios-y-costos/indice-de-precios-al-consumidor-ipc
21. Estadisticas DAN. Proyecciones de poblacion 2018 [03/07/2019].
Available from:https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion.
22. la Bd, Republica. Tasa Representativa del Mercado (TRM - Peso por
dólar) 2019 [cited 2020. Available from:https://www.banrep.gov.co/es/estadisticas/trm.
23. Departamento, Nacional, (DANE) DE. Archivo Nacional de Datos 2019
[Available from:https://sitios.dane.gov.co/anda-index/.
24. Chiou CF, Weaver MR, Bell MA, Lee TA, Krieger JW. Development of the
multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM). Int J
Qual Health Care. 2005;17(1):23-30.
25. Felli JC, Hazen GB. Sensitivity analysis and the expected value of
perfect information. Med Decis Making. 1998;18(1):95-109.
26. Neffen H, Fritscher C, Schacht FC, Levy G, Chiarella P, Soriano JB,
et al. Asthma control in Latin America: the Asthma Insights and Reality
in Latin America (AIRLA) survey. Rev Panam Salud Publica.
2005;17(3):191-7.
27. Garcia E, Aristizabal G, Vasquez C, Rodriguez-Martinez CE, Sarmiento
OL, Satizabal CL. Prevalence of and factors associated with current
asthma symptoms in school children aged 6-7 and 13-14 yr old in Bogota,
Colombia. Pediatr Allergy Immunol. 2008;19(4):307-14.
28. Global Iniciative for Asthma Management and Prevention 2020
[Available from:www.ginaasthma.org.
29. Colciencias MdSyPS-. Guía de Práctica Clínica Para el diagnóstico,
atención integral y seguimiento de niños y niñas con diagnóstico de
Asma. Guía No. 01 2014 [Available from: ,http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Conv_500/GPC_asma/GPC_Comp_Asma.pdf.
30. Petrou S, Boland A, Khan K, Powell C, Kolamunnage-Dona R, Lowe J, et
al. Economic evaluation of nebulized magnesium sulphate in acute severe
asthma in children. Int J Technol Assess Health Care. 2014;30(4):354-60.
31. Buendia JA. [Attitudes, knowledge and beliefs of patient about
anti-hypertensive drugs]. Biomedica. 2012;32(4):578-84.
32. Buendia JA, Otamendi E, Kravetz MC, Cairo F, Ruf A, de Davila M, et
al. Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus
Pharmacokinetics in Liver Transplant Patients. Exp Clin Transplant.
2015;13(5):441-8.
33. Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA.
Advantage of inhaled corticosteroids as additional therapy to systemic
corticosteroids for pediatric acute asthma exacerbations: a
cost-effectiveness analysis. J Asthma. 2019:1-10.
Acknowledgements : none
Conflict of interest statement for all authors : All authors
declare that they do not have any conflict of interest in this
publication.